Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Predicting the Clinical Course of Treatment with Midostaurin in Patients with Advanced Systemic Mastocytosis

Johannes Lübke, Nicole Naumann, Timo Brand, Hans-Peter Horny, Martina Rudelius, Karl Sotlar, Georgia Metzgeroth, Alice Fabarius, Wolf-Karsten Hofmann, Juliana Schwaab, Andreas Reiter

Blood (2023) 142 (Supplement 1): 1834.

https://doi.org/10.1182/blood-2023-182322

Published: 2023

Journal Articles

Human Induced Pluripotent Stem Cell-Derived Bone Marrow Organoids to Model Hematopoietic Development

Blood (2023) 142 (Supplement 1): 2708.

https://doi.org/10.1182/blood-2023-184523

Published: 2023

Journal Articles

Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies

Blood (2023) 142 (Supplement 1): 4358.

https://doi.org/10.1182/blood-2023-174384

Published: 2023

Journal Articles

UBTF tandem Duplications Account for a Third of Advanced Pediatric MDS without Genetic Predisposition to Myeloid Neoplasia

Blood (2022) 140 (Supplement 1): 1355–1356.

https://doi.org/10.1182/blood-2022-159002

Published: 2022

Journal Articles

Generation of Human Induced Pluripotent Stem Cell-Derived Bone Marrow Organoids

Stephanie Frenz, Isabel Goek, Maximilian Buser, Kirill Salewskij, Savannah Fairley, Raffaele Conca, Nicole Drexler, Gustav Jonsson, Moritz Thomas, Yoko Mizoguchi, Martina Rudelius, Thomas Heuser, Carsten Marr, Josef M Penninger, Christoph Klein

Blood (2022) 140 (Supplement 1): 1682–1683.

https://doi.org/10.1182/blood-2022-166653

Published: 2022

Journal Articles

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans-Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso-Ramos, Jorge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S. Hobbs, Ronald Hoffman, Elias J. Jabbour, Jean-Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L.-C. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte Niemeyer, Olatoyosi M. Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P. Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A. Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi

Blood (2022) 140 (11): 1200–1228.

https://doi.org/10.1182/blood.2022015850

Published: 2022

Includes: Supplemental data

Journal Articles

ARID1A Controls a Novel Transcriptional Network Regulating FAS in Follicular Lymphoma

Martina Antoniolli, Maria Solovey, Deepak Bararia, Carolin Dorothea Strobl, William David Keay, Johannes Adrian Hildebrand, Michael Heide, Verena Passerini, Lucas Wange, Wolfgang Enard, Susanne Thieme, Helmut Blum, Martina Rudelius, Sebastian Bultmann, Heinrich Leonhardt, Marion Subklewe, Michael von Bergwelt, Maria Colomé-Tatché, Oliver Weigert

Blood (2021) 138 (Supplement 1): 3492.

https://doi.org/10.1182/blood-2021-148862

Published: 2021

Journal Articles

CHOP but Not Bendamustine Reverses EZH2 Y641 Mutation Induced MHC-I/II Loss in Human Lymphoma Models

Louisa Catharina Adolph, Quentin Fichaux, Carolin Dorothea Strobl, Martina Antoniolli, Verena Passerini, William David Keay, Vindi Jurinovic, Axel Lechner, Daniel J. Hodson, Michael von Bergwelt, Marion Subklewe, Martina Rudelius, Oliver Weigert

Blood (2021) 138 (Supplement 1): 2391.

https://doi.org/10.1182/blood-2021-144803

Published: 2021

Journal Articles

Increased Bone Marrow Iron at Diagnosis Is Associated with Inferior Prognosis in Patients with Myelodysplastic Syndromes

Annika Kasprzak, Sandra Becker, Martina Rudelius, Corinna Strupp, Kathrin Nachtkamp, Judith Strapatsas, Barbara Hildebrandt, Norbert Gattermann, Ulrich Germing

Blood (2021) 138 (Supplement 1): 3700.

https://doi.org/10.1182/blood-2021-152402

Published: 2021

Journal Articles

The IMiD-Target Cereblon Determines Transmembrane Protein Quality Control Promoting Tumor Metabolism

Michael Heider, Ruth Eichner, Jacob Stroh, Anna Kuisl, Jana Zecha, Jannis Lawatscheck, Martina Rudelius, Anne-Kathrin Garz, Simone Lemeer, Christian Peschel, Ulrich Keller, MD, Katharina Götze, Johannes Buchner, Bernhard Kuster, Vanesa Fernandez-Saiz, Florian Bassermann, MD PhD

Blood (2019) 134 (Supplement_1): 314.

https://doi.org/10.1182/blood-2019-129064

Published: 2019

Journal Articles

The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2

Blood (2019) 134 (Supplement_1): 3741.

https://doi.org/10.1182/blood-2019-125973

Published: 2019

Journal Articles

Multicenter Case Series of Primary Adrenal Lymphoma (PAL)

Blood (2017) 130 (Supplement 1): 1562.

https://doi.org/10.1182/blood.V130.Suppl_1.1562.1562

Published: 2017

Journal Articles

Altered Expression of Neddylation Pathway Proteins in Myelodysplastic Syndromes

Fatemeh Majidi, MD, Judith Neukirchen, MD, Simon Brille, Iris Fey, BSc., Frank Neumann, MDPhD, Allison Berger, PhD, Ron-Patrick Cadeddu, PhD, Martina Rudelius, MD, Ulrich Germing, MD, Rainer Haas, MD, Norbert Gattermann, MD

Blood (2017) 130 (Supplement 1): 5298.

https://doi.org/10.1182/blood.V130.Suppl_1.5298.5298

Published: 2017

Journal Articles

JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma

Antonio Solimando, MD, Andreas Brandl, PhD, Mattenheimer Katharina, Carolin Graf, Miriram Ritz, Anna Ruckdeschel, Thorsten Stühmer, PhD, Martina Rudelius, MD, Maria Antonia Frassanito, PhD, Rosenwald Andreas, MD, Franz Jakob, MD, Angelo Vacca, MD, Hermann Einsele, MD, Andreas Beilhack, MD

Blood (2016) 128 (22): 307.

https://doi.org/10.1182/blood.V128.22.307.307

Published: 2016

Journal Articles

Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma – a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature

Sabine Steidle, MD, Tobias Dechow, MD, Katharina Götze, Martina Rudelius, MD, Konstanze Pechloff, PhD, Kerstin Behnke, Lars Bullinger, MD PhD, Falko Fend, MD, Soberon Valeria, PhDstudent, Marc Schmidt-Supprian, PhD, Florian Bassermann, MD, Jürgen Ruland, MD, Christian Peschel, MD, Ulrich Keller, MD

Blood (2014) 124 (21): 648.

https://doi.org/10.1182/blood.V124.21.648.648

Published: 2014

Journal Articles

[68Ga]Pentixafor: A Novel PET Tracer for Imaging CXCR4 Status in Patients with Multiple Myeloma

Blood (2014) 124 (21): 2014.

https://doi.org/10.1182/blood.V124.21.2014.2014

Published: 2014

Journal Articles

Myc Commands an Aurora Kinase – Sumoylation Circuit Required for B Cell Lymphoma Growth and Survival

Alexander Hoellein, MD, Stephanie Schoeffmann, Fallahi Mohammad, PhD, John L Cleveland, PhD, Johannes Gloeckner, PhD, Marius Ueffing, PhD, Martina Rudelius, MD, Christian Peschel, MD, Ulrich Keller, MD

Blood (2014) 124 (21): 3107.

https://doi.org/10.1182/blood.V124.21.3107.3107

Published: 2014

Journal Articles

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma

Alexander Hoellein, Mohammad Fallahi, Stephanie Schoeffmann, Sabine Steidle, Franz X. Schaub, Martina Rudelius, Iina Laitinen, Lisa Nilsson, Andrei Goga, Christian Peschel, Jonas A. Nilsson, John L. Cleveland, Ulrich Keller

Blood (2014) 124 (13): 2081–2090.

https://doi.org/10.1182/blood-2014-06-584524

Published: 2014

Includes: Supplemental data

Journal Articles

Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)

Catharina Müller-Thomas, MD, Martina Rudelius, MD, Ina Rondak, PhD, Torsten Haferlach, MD, Julie Schanz, MD, Burkhard Schmidt, MD, Markus Kremer, MD, Ulrich Germing, MD, Uwe Platzbecker, MD, PhD, Christian Peschel, Katharina Götze, MD

Blood (2013) 122 (21): 2797.

https://doi.org/10.1182/blood.V122.21.2797.2797

Published: 2013

Journal Articles

Activated Sumoylation Is a Hallmark Of Burkitt's Lymphoma and MYC Driven Cancer Leading To Synthetic Lethal Interactions With Sumoylation Inhibitors

Alexander Hoellein, MD, Sabine Steidle, MD, Mohammad Fellahi, PhD, Stephanie Schoeffmann, Martina Rudelius, MD, Christian Peschel, John L Cleveland, Ulrich Keller

Blood (2013) 122 (21): 3783.

https://doi.org/10.1182/blood.V122.21.3783.3783

Published: 2013

NARROW

Predicting the Clinical Course of Treatment with Midostaurin in Patients with Advanced Systemic Mastocytosis

Human Induced Pluripotent Stem Cell-Derived Bone Marrow Organoids to Model Hematopoietic Development

Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies

UBTF tandem Duplications Account for a Third of Advanced Pediatric MDS without Genetic Predisposition to Myeloid Neoplasia

Generation of Human Induced Pluripotent Stem Cell-Derived Bone Marrow Organoids

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

ARID1A Controls a Novel Transcriptional Network Regulating FAS in Follicular Lymphoma

CHOP but Not Bendamustine Reverses EZH2 Y641 Mutation Induced MHC-I/II Loss in Human Lymphoma Models

Increased Bone Marrow Iron at Diagnosis Is Associated with Inferior Prognosis in Patients with Myelodysplastic Syndromes

The IMiD-Target Cereblon Determines Transmembrane Protein Quality Control Promoting Tumor Metabolism

The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2

Multicenter Case Series of Primary Adrenal Lymphoma (PAL)

Altered Expression of Neddylation Pathway Proteins in Myelodysplastic Syndromes

JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma

Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma – a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature

[68Ga]Pentixafor: A Novel PET Tracer for Imaging CXCR4 Status in Patients with Multiple Myeloma

Myc Commands an Aurora Kinase – Sumoylation Circuit Required for B Cell Lymphoma Growth and Survival

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma

Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)

Activated Sumoylation Is a Hallmark Of Burkitt's Lymphoma and MYC Driven Cancer Leading To Synthetic Lethal Interactions With Sumoylation Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only